본문 바로가기

Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
DRUG SAFETY46(7) · pp.647 · 2023
피인용
Web of Science 6Scopus 4
FWCI (Scopus)
0.44
JCR IF
JCR 2022 4.2
ISSN
0114-5916

저자

  1. Choe, Seon제1저자Seoul Natl Univ, Syst Biomed Informat Res Ctr, Div Biomed Informat, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
  2. Lee, SuhyunUlsan Univ Hosp, Dept Prevent Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea
  3. Park, Chan HeeSeoul Natl Univ, Syst Biomed Informat Res Ctr, Div Biomed Informat, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
  4. Lee, Jeong HoonSeoul Natl Univ, Syst Biomed Informat Res Ctr, Div Biomed Informat, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
  5. Kim, Hyo JungSamsung Med Ctr, Res Inst Future Med, Ctr Res Resource Standardizat, Seoul, South Korea
  6. Byeon, Sun-juHallym Univ, Dept Pathol, Coll Med, Chunchon, South Korea
  7. Choi, Jeong-HeeHallym Univ, Dept Internal Med, Dongtan Sacred Heart Hosp, Hwaseong, South Korea
  8. Yang, Hyeon-JongSoonchunhyang Univ, Coll Med, Dept Pediat, Seoul Hosp, Seoul, South Korea
  9. Sim, Da WoonChonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Allergy & Clin Immunol, Med Sch, Gwangju, South Korea
  10. Cho, Bum-JooHallym Univ, Dept Ophthalmol, Coll Med, Chunchon, South Korea
  11. Koo, HoseokInje Univ, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea
  12. Kang, Min-GyuChungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea
  13. Jeong, Ji BongSeoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea
  14. Choi, In YoungCatholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea
  15. Kim, Sae-HoonSeoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
  16. Kim, Woo JinKangwon Natl Univ, Dept Internal Med, Coll Med, Chunchon, South Korea
  17. Jung, Jae-WooChung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  18. Lhee, Sang-HoonNaeun Hosp, Dept Prevent Med, Incheon, South Korea
  19. Ko, Young-JinCM Gen Hosp, Seoul, South Korea
  20. 박혜경Pusan Natl Univ, Dept Internal Med, Coll Med, Busan, South Korea
  21. Kang, Dong Yoon교신저자Gachon Univ, Dept Comp Engn, Seongnam, South Korea
  22. Kim, Ju Han교신저자Seoul Natl Univ, Syst Biomed Informat Res Ctr, Div Biomed Informat, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea

초록

Introduction: With the availability of retrospective pharmacovigilance data, the common data model (CDM) has been identified as an efficient approach towards anonymized multicenter analysis; however, the establishment of a suitable model for individual medical systems and applications supporting their analysis is a challenge. Objective: The aim of this study was to construct a specialized Korean CDM (K-CDM) for pharmacovigilance systems based on a clinical scenario to detect adverse drug reactions (ADRs). Methods: De-identified patient records (n = 5,402,129) from 13 institutions were converted to the K-CDM. From 2005 to 2017, 37,698,535 visits, 39,910,849 conditions, 259,594,727 drug exposures, and 30,176,929 procedures were recorded. The K-CDM, which comprises three layers, is compatible with existing models and is potentially adaptable to extended clinical research. Local codes for electronic medical records (EMRs), including diagnosis, drug prescriptions, and procedures, were mapped using standard vocabulary. Distributed queries based on clinical scenarios were developed and applied to K-CDM through decentralized or distributed networks. Results: Meta-analysis of drug relative risk ratios from ten institutions revealed that non-steroidal anti-inflammatory drugs (NSAIDs) increased the risk of gastrointestinal hemorrhage by twofold compared with aspirin, and non-vitamin K anticoagulants decreased cerebrovascular bleeding risk by 0.18-fold compared with warfarin. Conclusion: These results are similar to those from previous studies and are conducive for new research, thereby demonstrating the feasibility of K-CDM for pharmacovigilance. However, the low quality of original EMR data, incomplete mapping, and heterogeneity between institutions reduced the validity of the analysis, thus necessitating continuous calibration among researchers, clinicians, and the government.

식별자

Scopus EID
2-s2.0-85160253513
WoS UID
000995941200003